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Abstract:  In this study we present the real-time monitoring of three key brain 
neurochemical species in conscious rats using implantable amperometric electrodes 
interfaced to a biotelemetric device. The new system, derived from a previous design, was 
coupled with carbon-based microsensors and a platinum-based biosensor for the detection 
of ascorbic acid (AA), O2 and glucose in the striatum of untethered, freely-moving rats. 
The miniaturized device consisted of a single-supply sensor driver, a current-to-voltage 
converter, a microcontroller and a miniaturized data transmitter. The redox currents were 
digitized to digital values by means of an analog-to-digital converter integrated in a 
peripheral interface controller (PIC), and sent to a personal computer by means of a 
miniaturized AM transmitter. The electronics were calibrated and tested in vitro under 
different experimental conditions and exhibited high stability, low power consumption and 
good linear response in the nanoampere current range. The in-vivo results confirmed 
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previously published observations on striatal AA, oxygen and glucose dynamics recorded 
in tethered rats. This approach, based on simple and inexpensive components, could be 
used as a rapid and reliable model for studying the effects of different drugs on brain  
neurochemical systems. 
Keywords: Biotelemetry; microsensor; biosensor; glucose; oxygen; ascorbic acid. 
 
1. Introduction 
 
Details of the links between neurochemical and brain physiological functions or neurodegenerative 
diseases are mostly unknown. Because of its high energy metabolism, related to anatomical 
characteristics and physiology, the central nervous system (CNS) is assumed to be particularly 
sensitive to reactive oxygen species (ROS). Oxidative stress (OS) is crucial for the modulation of 
fundamental cellular functions such as apoptosis, calcium mobilization, and ion transport, all of which 
are involved in excitotoxicity. [1]. OS results from a disparity involving the physiological antioxidant 
capability and free radical synthesis [2]. Ascorbic acid (AA) is a water soluble vitamin that possesses 
radical scavenger properties against ROS [3], and represents the most important low molecular weight 
antioxidant in the brain. Even if not synthesized in humans, AA is an essential component of a healthy 
diet and the presence of a specific transporter (SVCT2) allows its internalization in neurons reaching a 
concentration 200-fold greater than in blood [4]. AA is readily oxidized to dehydroascorbate (DHAA) 
that can undergo irreversible hydrolysis to 2,3-diketo-L-gulonic acid, but because of its crucial role in 
CNS, DHAA is readily reconverted to AA to prevent vitamin C depletion. AA is also implicated in the 
protection against the excitotoxicity associated with high glutamate extracellular concentration through 
ascorbate/glutamate hetero-exchange [5,6]. Brain AA levels can be monitored amperometrically, using 
a carbon electrode poised at a mild anodic applied potential [5]: 
L-Ascorbic Acid → DHAA + 2e
– + 2H
+ (1) 
Oxygen, an essential molecule for life, is utilized not only for cellular respiration but also for 
biosynthesis and metabolism of various important biomolecules such steroids, eicosanoids, and 
neuroactive substances [7]. Oxygen is also implicated in several biochemical reactions involving for 
instance ATP in the brain [8]. Monitoring oxygen concentration dynamics could give important 
information about brain energy metabolism related to glucose [9] or lactate consumption [10]. The 
two-step electrochemical reduction of oxygen can achieved through amperometrically at a carbon-
epoxy sensor surface as follows [8]: 
O2 + 2H
+ + 2e
– → H2O2 (2) 
H2O2 + 2H
+ + 2e
– → 2H2O (3) 
Glucose is actively involved in ATP synthesis and its concentration in extracellular spaces is the 
most important factor for energy metabolism [9,11,12]. Glucose detection is possible by means of a 
glucose oxidase (GOx)-based biosensor. GOx is covalently linked with flavin adenine dinucleotide 
(FAD) [13] and is extremely reliable because of its good sensitivity to the enzyme substrate and high Sensors 2009, 9                        
 
 
2513
stability when immobilized on Pt electrodes by means of poly-orthophenylenediamine (pOPD) [11,14]. 
Reactions occur as follows: 
β-D-glucose + FAD
+-oxidase → D-glucono-δ- lactone + FADH2-oxidase (4) 
FADH2-oxidase + O2→ FAD-oxidase + H2O2 (5) 
By applying a positive potential of 700 mV to the Pt working electrode, versus a Ag/AgCl reference 
electrode, the electrochemical oxidation of hydrogen peroxide occurs as follows: 
H2O2 → O2 + 2e
– + 2H
+ (6) 
where the current produced by (6) is proportional to the concentration of glucose transformed by  
the enzyme.  
Nowadays the most frequent use for biotelemetry is in medicine, in cardiac care units or step-down 
units in hospitals [15,16,17]. In this study, we present a wireless device connected to microsensors or 
biosensors capable of detecting rapid changes of AA, O2 and Glucose concentrations in the striatum of 
untethered freely-moving rats. The intrinsic chemical characteristics of these molecules allow their 
detection using specific telemetric devices able to work in oxidation [18,19] or in reduction [8] mode. 
 
2. Results and Discussion 
 
2.1. Biotelemetric device test and calibration 
 
The electronic circuit of the miniaturized biotelemetric device was composed by three different 
parts: the amperometric module, the microcontroller and the transmitter. As described in Section 3.2 
below, the amperometric module was made using three “rail-to-rail” operational amplifiers working as 
potentiostat (OPA1), voltage follower (OPA2) and current-to-voltage (I/V) converter (OPA3). The 
Zener diode (Z) plays a pivotal role in the amperometric circuitry generating a fixed voltage of 1.22 V 
useful for the fine regulation of the potential applied (VApp) to the working electrode by means of a 
miniaturized potentiometer (P). The non-inverting input of OPA1 can be alternatively grounded or 
connected to Z for working in oxidation or reduction mode respectively. The transfer function of the 
I/V converter is: 
VOut = -(Iredox · Rf) + VApp (7) 
in which Iredox is the current flowing through the WE, Rf is the feedback resistor and VApp is the 
potential applied to the WE. Rf has a capacitor in parallel (Cf) to complete a low pass filter with a cut-
off frequency (Fcut-off) of 25 Hz. The value of Cf was calculated in farads according to the equation: 
Cf = 1 / (Fcut-off · 2π · Rf) (8) 
An automated dummy cell was made based on a previously published design [8,20] for testing the 
amperometric module of the biotelemetric device. The calibration of the electronics was made indoors 
with a linear distance between the TX and RX units of about 3 m confirming previously-published 
results [8]. The averaged power consumption necessary to drive the biotelemetric device was 
experimentally determined [8,20,21] as 375 µW (125 µA). This means that a 3 V lithium coin battery Sensors 2009, 9                        
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(Maxell CR1216), having a capacity of 25 mA h
–1, can power the unit for more than one week of 
continuous operation (sample rate: 1 Hz). The current necessary to drive the receiver unit was equal to 
45 mA (225 mW). The biotelemetric device is characterized by gain precision, stability and an 
excellent linear response. The system can operate both in oxidation and reduction modes and it is 
particularly suited to work with direct-oxidation sensors (AA) or biosensors based on oxidase enzymes 
(glucose) and direct-reduction sensors (O2) or O2-consuming biosensors [22]. The weight of the 
biotelemetry unit is compatible with similar commercial devices [23], represents ~ 3% of the rat body 
weight and it is well tolerated by the animals in agreement with other studies [24].  
 
2.2. In-vitro calibration of ascorbic acid microsensor and in-vivo results 
 
In-vitro calibrations of AA microsensors were carried out in fresh PBS at room temperature (25 °C) 
before and after implantation. A constant potential of +120 mV vs Ag/AgCl was applied and, after a 
stable baseline was reached, known amount of AA stock solution were added to the PBS in order to 
obtain concentrations ranging from 0 to 1 mM.  
Figure 1. Physiological and pharmacologically-induced changes of striatal ascorbic acid. 
(A) AA microsensor in-vivo stabilization. (B) Striatal AA physiological changes during 
eating (a) and grooming (b). (C) Effect of saline (a) and sodium ascorbate (b) (1 gr kg
–1 i.p. 
administration) on striatal AA current. (D) Effect of d-amphetamine (2 mg kg
–1 s.c. 
administration) (a) on striatal AA current and motor activity. 
 
 
Before implantation, microsensors showed good sensitivity and good linearity (7.3 pA µM
–1, R
2 = 
0.9959). Post-implantation sensitivity dropped by about 60% (2.9 pA µM
-1), but maintained a good 
linearity (R
2 = 0.9959). In-vivo experiments started 24 h after implantation. A stable baseline was Sensors 2009, 9                        
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reached after a period of about 20 min (see Figure 1A). The calculated AA baseline corresponded to a 
concentration of ~ 350 µM, in agreement with previous findings [25]. Physiological fluctuations of AA 
current were observed in concomitance with stereotyped behaviors (see Figure 1B). Pharmacological 
treatments were performed by administering sodium ascorbate (1 gr kg
–1 i.p.) and d-amphetamine (2 
mg kg
–1 s.c.). Sodium ascorbate was administered intraperitoneally in order to verify sensor response 
and resulted in a 4-fold increase in striatal AA current (see Figure 1C). Subcutaneous d-amphetamine 
(see Figure 1D) induced an increase in AA current (+0.40 nA corresponding to +138 µM) and motor 
activity in accord with previous studies [26]. D-Amphetamine has also been shown to decrease 
glutamate striatal concentrations [26]. These findings are consistent with the functioning of an 
AA/glutamate heteroexchange system [6,27] in which AA release is linked to impulse traffic, 
transmitter release and glutamate uptake [26]. 
 
2.3. In-vitro calibration of oxygen microsensor and in-vivo results 
 
All  in-vitro calibrations of oxygen microsensors were carried out 24 h after manufacture, 
immediately before implantation and then repeated after in-vivo  experiments, using a previously-
described electrochemical cell [20,21], appropriately set for oxygen [8].  
Figure 2. Effect of physiological stimulation on striatal dissolved oxygen. A 5-min tail 
pinch was applied to untethered, freely-moving rats resulting in an enhancement in motor 
and chewing activities, with an onset of a few seconds after the paper clip application, and 
a concomitant increase in striatal O2 current. Delta-I: inverted baseline-subtracted current. 
 
 
The calibration performed before implantation exhibited good linearity with a slope of 213 ± 2 pA 
µM
–1 of O2 (R
2 = 0.989; n = 6), whilst the calibration made after implantation showed a reduction in 
sensitivity against O2 (-18%), in line with previous observations [8]. In-vivo experiments started 24 h 
after implantation. A stable baseline (19.7 ± 3.2 nA; n = 6) was reached after a period of about 45 min. 
Considering that the averaged background current of the microsensor in nitrogen-saturated PBS (day 0 
and day 8) was around 14 nA, it is possible to estimate the concentration of O2 using in-vitro pre- and 
post-calibrations; this was found to correspond to 33 ± 14 μM, a value consistent with previous Sensors 2009, 9                        
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estimates. [28,29,30-32]. Physiological stimulation, a 5 min-tail pinch (see Figure 2), administered in 
order to increase neural activity and to promote regional cerebral blood flow (rCBF), led to increased 
motor activity and striatal O2 current of +4.8 nA, corresponding to +27 µM. Striatal oxygen dynamics, 
following physiological stimulation, results in a rise in the local O2 signal [8], mainly related to an 
increase of rCBF during neural activation in agreement with previous reports on wired rats [8,28,29]. 
 
2.4. In-vitro calibration of glucose biosensor and in-vivo results 
 
The in-vitro response of the glucose biosensor was determined just before implantation by adding 
known amounts of glucose in the electrochemical cell giving concentrations ranging between 0 and 
140 mM. Calibrations showed classical Michaelis-Menten kinetics (R
2 = 0.989, n = 6) with Vmax and 
KM equal respectively to 89 ± 4 nA and 4.8 ± 0.6 mM. The linear region was evaluated at low 
concentrations (0 – 2 mM), which showed good linearity (R
2 = 0.987, n = 6) with a slope of 15.2 ± 1.1 
nA mM
–1. The in-vivo experiments were carried out using the same procedures as oxygen studies. A 
stable baseline was observed 30 – 35 min after sensor polarization and corresponded to 7.5 ± 0.5 nA 
(492 ± 35 µM from the above in-vitro calibration), in agreement with previous findings [11]. A 5-min 
tail pinch (see Figure 3) resulted in an initial decrease of glucose signal during stimulus administration, 
followed by an increase of glucose current which then returned to baseline after ~ 30 min. These 
results are suggestive of glucose consumption during neural activation followed by an increase of 
extracellular levels of glucose, possibly due to astroglial glycogenolysis [33].  
Figure 3. Effect of physiological stimulation on striatal glucose current. A 5-min tail pinch 
was applied to untethered, freely-moving rats resulting in an enhancement in motor and 
chewing activities with a concomitant decrease of glucose signal during stimulus 
administration followed by an increase of glucose current which then returned to baseline. 
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3. Experimental Section 
 
3.1. Reagents, solutions and electronic parts 
 
All chemicals were analytical reagent grade or higher purity and dissolved in bidistilled deionized 
water (MilliQ
®). Ascorbic acid, sodium ascorbate, uric acid, dopamine, 3,4-dihydroxyphenylacetic 
acid (DOPAC), D-(+)-glucose, glucose oxidase from Aspergillus Niger (EC 1.1.3.4), o-
phenylenediamine (OPD), Nafion
® (5% in aliphatic alcohols) and D-amphetamine were purchased 
from Sigma-Aldrich (Milano, Italy). The phosphate-buffered saline (PBS, 20 mM) solution was made 
using 0.15 M NaCl, 0.04 M NaH2PO4 and 0.04 M NaOH from Sigma, and then adjusted to pH 7.4. 
GOx solution was prepared by dissolving 180 units of enzyme in 10 µL of PBS and stored at -30 °C. 
The OPD monomer (250 mM) was dissolved in deoxygenated PBS immediately before use. Stock 
solutions of AA (100 mM) were prepared daily in water immediately before use, while the stock 
solution of glucose (1 M) was prepared in water as previously described [21]. Solutions were kept at 4 
°C when not in use. Ultrapure (> 99.9%) oxygen (O2) and nitrogen (N2) were acquired from Sapio s.r.l 
Special Gases Division (Caponago, Italy). N2-purged and O2-saturated solutions, used for in-vitro 
calibrations, were obtained by bubbling the corresponding gas in 10 mL of PBS for 60 min. The air-
saturated solution of PBS (21% O2) was obtained by dissolving filtered air in 10 mL of PBS for 1 h, 
using a diaphragm air pump. All in-vitro calibrations of oxygen microsensors were performed using 
freshly-prepared N2 and O2 solutions under standard conditions of pressure and temperature [8]. 
Electronic parts were from Farnell-In-One spa (Milano, Italy), the radio modules were from 
Telecontrolli spa (TC, Casoria, Italy) and the USB components preassembled by Futura Elettronica srl 
(Gallarate, Italy).  
 
3.2. Biotelemetric device 
 
The amperometric section of the biotelemetric device (see Figure 4), weighing less than 10 grams, 
was built using a quad single-supply operational amplifier MCP6044 (Arizona Microchip, Chandler, 
AZ, USA) and a ZXRE4001 Zener diode (Zetex, Manchester, UK). The ADC was an integral part of 
the microcontroller (PIC12F683, Arizona Microchip) used in this system. The 433.92 MHz AM 
transmitter was a RT4-433.92 (TC) while the RR3-433.92 module (TC) was selected as the AM 
receiver. Both TC modules were equipped with external antennas. The serial-to-USB converter was a 
FTDI-FT232R module with internal E2PROM and integrated clock synthesizer. All capacitors were 
NP0-type multilayer ceramic (low pass ﬁlter, decoupling) or electrolytic (decoupling). All resistors 
were precision metal oxide thick ﬁlm (250 mW, 0.1% tolerance, Ohmite, Rolling Meadows, IL, USA). 
The components were soldered on single side PCB boards produced as previously described [8]. All 
electronic parts used in this project were Pb-free and compliant to RoHS directives. The biotelemetric 
device was derived from previous designs [8,20,21] and is capable of working in both oxidation (Ox) 
and reduction (Red) modes. 
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Figure 4. Amperometric section of the biotelemetric device. Ox: Oxidation; Red: 
Reduction; Z: Zener diode; P: Potentiometer; OPA: Operational Amplifier; Rf: Feedback 
Resistor; Cf: Feedback Capacitor; VApp: Applied Potential; VOut: Output Voltage; WE: 
Working Electrode; RE: Reference Electrode; AE: Auxiliary Electrode. 
 
 
3.3. Preparation and calibration of microsensors and biosensors 
 
The AA microsensors were made using Teflon™-insulated silver wires (30 mm in length; Ø = 125 
µm, Advent Research Materials, Suffolk, UK) modifying a previously-described procedure [34]. 
Approximately 1 mm of the wire was exposed and inserted into a silica capillary tube (10 mm in 
length; I.D. Ø = 180 µm, Polymicro Technologies, Phoenix, AZ, USA) partly filled with graphite-
loaded (55% w/w) epoxy resin (Araldite-M®, Sigma-Aldrich, Milan, Italy). A preliminary 180 µm 
diameter carbon-composite disc electrode (area: 2.5  10
–4 cm
2) was fabricated by mixing 850 mg of 
graphite with 500 mg of Araldite-M and 200 mg of hardener and filling the silica capillary tubing with 
the mixture. The silver wire guaranteed a good electrical contact. After 24 h at 40 °C, the shape of the 
WE was transformed from disc to conical (see Figure 5A) using a high speed drill (Dremel
® 300) 
equipped with an aluminum oxide grinding wheel. The final AA microsensors had a length ≈ 250 µm, 
a surface area ≈ 1.5  10
-3 cm
2 and a tip diameter < 25 µm, dimensions well below those associated 
with significant tissue trauma caused by the implantation of larger probes [8,35,36]. The O2 
microsensors (see Figure 5B) were manufactured in the same way as AA ones performing a further 
surface treatment with cellulose nitrate [8].  
Figure 5. Scanning Electron Microscopy (SEM) microphotographs of (A) ascorbic acid 
microsensor, (B) oxygen microsensor and (C) glucose biosensor used in this study. 
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AA oxidation and O2 reduction potentials were experimentally established using cyclic 
voltammetry and were found to be +120 mV [19] and -400 mV [8], respectively vs Ag/AgCl (NaCl 3 
M; RE4 Bioanalytical Systems, Inc., Lafayette, TX, USA) reference electrode. The fabrication of the 
glucose biosensors (see Figure 5C) has been previously described in detail [21]. Briefly, 1 mm Pt 
cylinder, obtained by cutting Teflon-insulated Pt wire (Ø = 125 µm, Advent Research Materials, 
Suffolk, UK), was immersed 3 times into a solution of GOx and let it dry for 5 min after each dip. The 
biosensor was then placed in the cell filled with 5 mL of N2-purged PBS containing the o-
phenylenediamine monomer (250 mM). The electrosynthesis of p-OPD was carried out at +700 mV 
vs. Ag/AgCl for 15 min. H2O2 electro-oxidation was carried out at +700 mV [21] vs Ag/AgCl 
reference electrode. Constant potential amperometry (CPA) was used for in-vitro and in-vivo 
experiments; all in-vitro calibrations were performed in fresh PBS 24 h after sensors’ fabrication as 
previously described in detail [8,19,21]. No significant interference signals were observed on exposing 
AA, O2 microsensors and glucose biosensors to other electroactive molecules present in the striatal 
extracellular fluid (ECF), even at pharmacologically relevant concentrations [37] (Table 1). 
Table 1. Effects of some electroactive molecules (AA, DOPAC, UA and DA) present in 
the striatal ECF on the amperometric response of the AA, O2 and glucose sensors. N.D.: 
(response) not detected. 
Interference 
AA microsensor 
(n = 4) 
O2 microsensor 
(n = 4) 
Glucose biosensor 
(n = 6) 
AA (500 µM)  3.65 ± 0.4 nA  N.D.  0.73 ± 0.2 nA 
DOPAC (10 µM)  31 ± 6 pA  N.D.  22 ± 5 pA 
UA (10 µM)  16 ± 7 pA  N.D.  27 ± 9 pA 
DA (1 µM)  N.D.  N.D.  55 ± 11 pA 
 
3.4. Animals, stereotaxic surgery and in-vivo experimental procedures 
 
Male Wistar rats (Morini R. Emilia, Italy), weighing 250 – 300 g were used in all experiments. Rats 
were kept under standard animal care conditions with 12 h light/dark cycle, and room temperature 21 
°C, food and water ad libitum. Before each experiment, the health of the animals was assessed 
according to published guidelines [38]. All procedures were licensed under the European Community 
directive 86/609 included in Decreto No. 116/1992 of the Italian Ministry of Public Health. Stereotaxic 
surgery was performed under chloral hydrate (400 mg kg
-1 i.p.) anesthesia. Microsensors and 
biosensors were implanted in the right striatum using the following coordinates from the atlas of 
Paxinos and Watson [39]: A/P +0.5 from bregma, +2.5 M/L, and -4.0 D/V from dura. Reference and 
auxiliary electrodes were implanted in the left parietal cortex and two screws were inserted in the 
skull. The biotelemetric device was fixed as previously described [8]. Body temperature during 
anesthesia was maintained at 37 °C by means of an isothermal heating pad. Following surgery, the 
animals were housed in large plastic bowls (45 cm diameter), and maintained in a temperature- and 
light- controlled environment, with free access to food and water. The sensors were polarized 24 h 
after surgery (day 1). The neurochemical monitoring started with the animal in its home bowl: this 
arrangement allowed the rat free movement. Physiological stimulation (tail pinch) and Sensors 2009, 9                        
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pharmacological treatments (sodium ascorbate and D-amphetamine) were carried out within the first 
week after stereotaxic surgery.  
 
3.5. Hystology 
 
After each set of experiments (day 8), rats were sacrificed with an injection of chloral hydrate (800 
mg kg
-1 i.p.). The location of each microsensor and biosensor in the striatum was confirmed by post-
mortem histology. Brains were fixed in formal saline and 50 µm coronal sections were made with a 
cryostat. The slices were stained with cresyl violet and examined under a microscope. 
3.6. Statistical analysis 
Concentrations of AA, O2 and glucose were expressed in µM. AA and glucose (H2O2) anodic 
signals were given as absolute current values (nA) while oxygen cathodic current was expressed in nA 
and given as baseline-subtracted (Delta-I) raw data. The sign of the oxygen currents was inverted to 
give a positive correlation of the plotted data with the concentration of analyte. The in-vitro response 
of AA and oxygen microsensors was evaluated before and after in in-vivo experiments while the 
glucose biosensors parameters were calculated only before implantation because of the damage during 
explant can lead to inaccurate calibration [40]. The changes of brain tissue neurochemicals were 
calculated as absolute variations versus the corresponding baselines and their striatal concentrations 
were estimated using pre-implantation (glucose) or post-implantation (AA and O2)  in-vitro 
calibrations.  
 
4. Conclusions 
 
In this study we present the real-time monitoring of three brain neurochemical species (AA, O2 and 
glucose) in untethered, freely-moving rats using a biotelemetric device coupled with implantable 
sensors. The transmitter and the receiver units have been used for accurate transduction of the redox 
currents generated on the surface of these microsensors and biosensors, both in vitro and in vivo. The 
miniaturized biotelemetric device, composed by an amperometric module, a microcontroller and a 
transmitter, polarizes the sensor and sends sensor data to a receiving unit connected to a PC. The 
system electronics have been tested under different experimental conditions exhibiting low power 
consumption, high stability and good linear response. The in-vivo results confirmed previously-
published observations on striatal AA, oxygen and glucose dynamics. This approach, based on simple 
and inexpensive components, could be used as a rapid and reliable model for studying the effects of 
different drugs on brain neurochemical systems. 
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